Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Standard Biotools (LAB) over the last 4 years, with Q3 2025 value amounting to $46.5 million.

  • Standard Biotools' Treasury Shares changed 0.0% to $46.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $46.5 million for FY2024, which is 67743.01% up from last year.
  • Standard Biotools' Treasury Shares amounted to $18.6 million in Q3 2025, which was up 20000.0% from -$18.6 million recorded in Q2 2025.
  • Standard Biotools' Treasury Shares' 5-year high stood at $18.6 million during Q4 2024, with a 5-year trough of -$18.6 million in Q2 2024.
  • Its 5-year average for Treasury Shares is -$1.7 million, with a median of $1.7 million in 2023.
  • Per our database at Business Quant, Standard Biotools' Treasury Shares skyrocketed by 96163.41% in 2023 and then changed by 0.0% in 2025.
  • Quarter analysis of 4 years shows Standard Biotools' Treasury Shares stood at $563000.0 in 2022, then surged by 961.63% to $6.0 million in 2023, then skyrocketed by 677.43% to $46.5 million in 2024, then changed by 0.0% to $46.5 million in 2025.
  • Its Treasury Shares stands at $46.5 million for Q3 2025, versus $46.5 million for Q2 2025 and $46.5 million for Q1 2025.